1 minute read

Portfolio case studies continued

How do you measure progress?

Ultimately, our goal is to bring new medicines to the patients who so desperately need them. We have clear milestones along the way to ensure that we are making progress towards our goal, beginning with identifying the right drug candidates to take into clinical development and ensuring that we have the necessary capabilities, people, resources, and partnerships to make that happen.

What has been the biggest challenge to date?

Our biggest challenge has been finding the right people to match to our scientific aspirations and our company values. Any time that a company sits on the precipice of the latest scientific and technological breakthroughs, it will naturally be a challenge to find people with the right training and experience. In our case, it has often been the need for experience and knowledge in both experimental biology and bioinformatics, along with the right cultural fit, that has proven to be a challenge. Nonetheless, we are excited by the quality of candidates that have presented themselves and the enthusiasm they have shown to be part of the Mosaic family. We will never compromise on our talent, and we have not had to.

What is next?

We will progress our drug candidate program towards IND-enabling studies, identify the right potential partnerships to grow our business, and search for the best talent in the industry to grow our team.